Gene targeting in NOD mouse embryos using zinc-finger nucleases

Diabetes

Volumn 63, Issue 1, 2014, Pages 68-74

  Chen, Yi Guang ^a   Forsberg, Matthew H ^a   Khaja, Shamim ^a   Ciecko, Ashley E ^a   Hessner, Martin J ^a   Geurts, Aron M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD137 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DX5 ANTIGEN; ENDOGLIN; GLYCOPROTEIN P 15095; LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 9; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETOGENESIS; DISEASE COURSE; EFFECTOR CELL; EMBRYO; EMBRYONIC STEM CELL; EXON; FEMALE; FLOW CYTOMETRY; GENE SILENCING; GENE TARGETING; GENETIC MANIPULATION; GENOTYPE; HISTOLOGY; HOMOZYGOSITY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MICROINJECTION; MOUSE; MUTAGENESIS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; STOP CODON; T LYMPHOCYTE; TISSUE CULTURE;

EID: 84891791730     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0192     Document Type: Article

References (24)

1. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980;29:1-13
2. Driver JP, Serreze DV, Chen YG. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol 2011;33:67-87
3. Vijayakrishnan L, Slavik JM, Illés Z, et al. An autoimmune diseaseassociated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 2004;20:563-575
4. Yamanouchi J, Rainbow D, Serra P, et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007;39:329-337
5. Gerold KD, Zheng P, Rainbow DB, Zernecke A, Wicker LS, Kissler S. The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes 2011;60:1955-1963
6. Hanna J, Markoulaki S, Mitalipova M, et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 2009;4:513-524
7. Nichols J, Jones K, Phillips JM, et al. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med 2009;15: 814-818
8. Morgan MA, Muller PS, Mould A, et al. The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice. PLoS ONE 2013;8:e56738
9. Kissler S, Stern P, Takahashi K, Hunter K, Peterson LB, Wicker LS. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat Genet 2006;38:479-483
10. Chen Z, Stockton J, Mathis D, Benoist C. Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc Natl Acad Sci USA 2006; 103:16400-16405
11. Geurts AM, Cost GJ, Rémy S, et al. Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol 2010;597:211-225
12. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010;11: 636-646
13. Wang C, Lin GH, McPherson AJ, Watts TH. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 2009;229:192-215
14. Lyons PA, Hancock WW, Denny P, et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 2000;13:107-115
15. Cannons JL, Chamberlain G, Howson J, et al. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. J Autoimmun 2005;25:13-20
16. Kachapati K, Adams DE, Wu Y, et al. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model. J Immunol 2012;189:5001-5015
17. Geurts AM, Cost GJ, Freyvert Y, et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 2009;325:433
18. Serreze DV, Osborne MA, Chen YG, et al. Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression. J Immunol 2006; 177:6675-6684
19. Chen YG, Scheuplein F, Driver JP, et al. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice. J Immunol 2011;186:4278-4284
20. Chen YG, Scheuplein F, Osborne MA, Tsaih SW, Chapman HD, Serreze DV. Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice. Diabetes 2008;57: 3273-3280
21. Shultz LD, Lang PA, Christianson SW, et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 2000;164:2496-2507
22. Carbery ID, Ji D, Harrington A, et al. Targeted genome modification in mice using zinc-finger nucleases. Genetics 2010;186:451-459
23. Cui X, Ji D, Fisher DA, Wu Y, Briner DM, Weinstein EJ. Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat Biotechnol 2011;29:64-67
24. Irie J, Wu Y, Kachapati K, Mittler RS, Ridgway WM. Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. Diabetes 2007;56:186-196